What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
Toshiaki A. Furukawa spends much of his time researching Psychiatry, Depression, Internal medicine, Randomized controlled trial and Quality of life.
His Psychiatry research focuses on Alexithymia in particular.
His study in Depression is interdisciplinary in nature, drawing from both Mental health, Physical therapy and Alcohol abuse.
His Internal medicine research integrates issues from Venlafaxine, Relapse prevention, CINAHL and Sertraline.
His research in Sertraline intersects with topics in Escitalopram, Tolerability, Systematic review, Duloxetine and Mirtazapine.
His work deals with themes such as Odds ratio, Clinical trial, Absolute risk reduction, Meta-analysis and Placebo, which intersect with Randomized controlled trial.
His most cited work include:
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis (1246 citations)
- Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review (658 citations)
- Cross-cultural validation of the Beck Depression Inventory-II in Japan. (290 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Psychiatry, Depression, Clinical psychology, Internal medicine and Psychometrics.
His research links Randomized controlled trial with Psychiatry.
His research integrates issues of Cancer, Psychosocial, Anxiety, Hemodialysis and Pediatrics in his study of Depression.
His Clinical psychology research also works with subjects such as
- Cronbach's alpha that intertwine with fields like Construct validity,
- Cognition that connect with fields like Degenerative disease, Cognitive psychology and Dementia.
His Internal medicine study combines topics in areas such as Antidepressant, Sertraline and Venlafaxine.
His Psychometrics research includes themes of Item response theory, Center for Epidemiologic Studies Depression Scale, Major depressive episode and Rating scale.
He most often published in these fields:
- Psychiatry (52.43%)
- Depression (29.13%)
- Clinical psychology (24.27%)
What were the highlights of his more recent work (between 2008-2020)?
- Psychiatry (52.43%)
- Clinical psychology (24.27%)
- Depression (29.13%)
In recent papers he was focusing on the following fields of study:
Psychiatry, Clinical psychology, Depression, Internal medicine and Mental health are his primary areas of study.
His Psychiatry research incorporates elements of Odds ratio and Risk factor.
His work on Psychometrics as part of general Clinical psychology study is frequently linked to Human sexuality, bridging the gap between disciplines.
Toshiaki A. Furukawa combines subjects such as Cancer, Physical therapy, Severity of illness and Rheumatoid arthritis with his study of Depression.
The concepts of his Internal medicine study are interwoven with issues in Mirtazapine and Oncology.
Toshiaki A. Furukawa has researched Mental health in several fields, including Alternative medicine, Public health and Comorbidity.
Between 2008 and 2020, his most popular works were:
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis (1246 citations)
- Depression, inflammation, and pain in patients with rheumatoid arthritis. (143 citations)
- Systematic review and meta-analysis of cannabis treatment for chronic pain. (140 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Major depressive disorder
Toshiaki A. Furukawa mostly deals with Psychiatry, Quality of life, Internal medicine, Hospital Anxiety and Depression Scale and Physical therapy.
His study in Psychiatry is interdisciplinary in nature, drawing from both Odds ratio, Randomized controlled trial, Meta-analysis, Placebo and Disease.
His Internal medicine research integrates issues from Venlafaxine, Escitalopram, Duloxetine and Citalopram.
His research investigates the link between Hospital Anxiety and Depression Scale and topics such as Psychological intervention that cross with problems in Clinical psychology.
His Physical therapy research is multidisciplinary, incorporating perspectives in Psychosocial, Cross-sectional study, Depression and Anxiety.
Toshiaki A. Furukawa is studying Beck Depression Inventory, which is a component of Depression.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
